Algernon Pharmaceuticals Inc C.AGN

Transparency

[Justforfun10]

If patient enrollment has not started in the Korean and Canadian trials I think the company needs to explain why? How difficult is it to administer 3 pills per day? Are patients opting for other treatments such as Remdisivir? Are they waiting for the successful development of the IV formulation? Each week that passes by without enrollment is burning available funds.

[BehStreet]

The "Korean" trial is being run by an indepependent CRO, Novotech, and, as stated in the webinar last week, Novotech won't divulge information until the trial has completed. I have already explained why patient enrollment is behind in South Korea, see my previous posts. As for the "Canadian" trial, it hasn't started yet. It is part* of the phase 2b/3 trial "

[TheBearInTheWoods]

it is funny how so many people are stepping into BIOTECH and expecting news tomorrow, to get FDA approval usually takes a year and costs a million. Health Canada isnt far off, as much as i dont like how Management spends money and treats shareholders, They are moving fast. Having a drug made and toxicoligy done takes time, Even for a repurposed drug, this usually takes years. their is a reason